Nyu Langone Medical Center

New York, New York 11021

18 studies enrolling now · 263 studies all time

What they study most

3rd Degree Heart Block, AV Block, AV Block Complete, Acute Coronary Syndrome, Acute DVT of Lower Extremity, Acute Kidney Injury, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Acute Pancreatitis, Adenoma, Advanced B-cell NHL

Studies at this site

• A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis — Recruiting now
• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
• A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) — Recruiting now
• A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer — Recruiting now
• Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1 — Recruiting now
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Recruiting now
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
• A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer — Recruiting now
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — Recruiting now
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — Recruiting now
• REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE — Recruiting now
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial — Recruiting now
• Heart Attack Research Program: Platelet Sub-Study (HARP) — Recruiting now
• Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis) — Recruiting now
• Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease — Recruiting now
• The Cancer of the Pancreas Screening-5 CAPS5)Study — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Research on Infarction With Open Arteries Using OCT and CMR — Running, not enrolling
• Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer — Stopped early
• A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis — Running, not enrolling
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC — Completed
• A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT — Completed
• The Protrieve PROTECTOR Study — Completed
• Cerliponase Alfa Observational Study in the US — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation — Stopped early
• HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors — Running, not enrolling
• SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial — Running, not enrolling
• Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection — Completed
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — Enrolling by invitation
• The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry) — Enrolling by invitation
• Cleaner Air for Lower Cardiometabolic Risk — Completed
• Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System — Completed
• Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement — Completed
• Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF — Completed
• Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome — Available (expanded access)
• RNS® System Epilepsy Post-Approval Study — Completed
• Women's Heart Attack Research Program: Stress Ancillary Study — Completed
• Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) — Completed
• Heart Attack Research Program- Imaging Study — Running, not enrolling
• Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors — Running, not enrolling
• INSPIRE Pipeline™ Shield Post Approval Study — Running, not enrolling
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors — Running, not enrolling